Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease

The use of dual antiplatelet therapy (a P2Y12 inhibitor plus aspirin) after percutaneous coronary intervention (PCI) reduces the risk of ischemic or atherothrombotic events, including stent thrombosis, recurrent myocardial infarction, and cardiovascular death. Approximately 5 to 7% of patients with…

Leave a Reply

Your email address will not be published. Required fields are marked *